DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,596,393 | -7.6% | 784,838 | +0.8% | 0.24% | +10.4% |
| Q2 2023 | $186,819,840 | -5.9% | 778,416 | -1.2% | 0.22% | -23.2% |
| Q1 2023 | $198,547,534 | -5.7% | 787,762 | -0.7% | 0.29% | -17.4% |
| Q4 2022 | $210,474,609 | -39.2% | 792,987 | -40.8% | 0.35% | -45.7% |
| Q3 2022 | $345,915,000 | +81.2% | 1,339,250 | +77.9% | 0.64% | +92.2% |
| Q2 2022 | $190,895,000 | -23.7% | 752,977 | -12.9% | 0.34% | -5.9% |
| Q1 2022 | $250,145,000 | +0.5% | 864,176 | +14.6% | 0.36% | -19.1% |
| Q4 2021 | $248,826,000 | -66.6% | 754,129 | -68.8% | 0.44% | -68.5% |
| Q3 2021 | $744,869,000 | +57.7% | 2,414,325 | +38.1% | 1.40% | +52.9% |
| Q2 2021 | $472,276,000 | +132.8% | 1,747,684 | +92.9% | 0.91% | +108.0% |
| Q1 2021 | $202,902,000 | -0.3% | 905,810 | -1.5% | 0.44% | -7.8% |
| Q4 2020 | $203,593,000 | -59.7% | 919,141 | -61.3% | 0.48% | -63.9% |
| Q3 2020 | $505,118,000 | +95.4% | 2,375,019 | +59.8% | 1.32% | +70.0% |
| Q2 2020 | $258,479,000 | +23.4% | 1,485,843 | +0.4% | 0.78% | +2.8% |
| Q1 2020 | $209,467,000 | -4.6% | 1,480,164 | +3.6% | 0.76% | +13.0% |
| Q4 2019 | $219,466,000 | -29.3% | 1,428,689 | -34.8% | 0.67% | -32.4% |
| Q3 2019 | $310,474,000 | -2.9% | 2,190,505 | -2.6% | 0.99% | -4.4% |
| Q2 2019 | $319,759,000 | -3.5% | 2,248,474 | -11.6% | 1.03% | -8.4% |
| Q1 2019 | $331,353,000 | +51.1% | 2,542,092 | +19.4% | 1.13% | +30.2% |
| Q4 2018 | $219,310,000 | +65.2% | 2,129,142 | +74.3% | 0.87% | +100.2% |
| Q3 2018 | $132,755,000 | +4.1% | 1,221,549 | -5.7% | 0.43% | +0.2% |
| Q2 2018 | $127,513,000 | +9.8% | 1,295,787 | +9.7% | 0.43% | +0.9% |
| Q1 2018 | $116,126,000 | +1.2% | 1,181,717 | -4.7% | 0.43% | +14.7% |
| Q4 2017 | $114,736,000 | +74.3% | 1,239,809 | +57.6% | 0.37% | +61.5% |
| Q3 2017 | $65,841,000 | -33.4% | 786,687 | -32.8% | 0.23% | -48.4% |
| Q2 2017 | $98,919,000 | +3.4% | 1,171,209 | +4.9% | 0.45% | +31.0% |
| Q1 2017 | $95,629,000 | +3.7% | 1,116,257 | -5.8% | 0.34% | +119.2% |
| Q4 2016 | $92,211,000 | +628.2% | 1,185,076 | +633.8% | 0.16% | +225.0% |
| Q3 2016 | $12,663,000 | -25.7% | 161,499 | -4.0% | 0.05% | -27.3% |
| Q2 2016 | $17,052,000 | -77.3% | 168,152 | -64.5% | 0.07% | -63.9% |
| Q1 2016 | $75,250,000 | -26.5% | 473,978 | -56.7% | 0.18% | -58.7% |
| Q4 2015 | $102,395,000 | -4.8% | 1,094,273 | -13.1% | 0.44% | -1.6% |
| Q3 2015 | $107,585,000 | -35.5% | 1,258,999 | -35.6% | 0.45% | -20.5% |
| Q2 2015 | $166,873,000 | +50.2% | 1,954,170 | +49.5% | 0.57% | +35.4% |
| Q1 2015 | $111,090,000 | -23.2% | 1,306,951 | -22.7% | 0.42% | -6.7% |
| Q4 2014 | $144,556,000 | -3.7% | 1,689,693 | -14.4% | 0.45% | -8.6% |
| Q3 2014 | $150,044,000 | -14.3% | 1,974,479 | -11.2% | 0.49% | -11.1% |
| Q2 2014 | $175,042,000 | +8.9% | 2,222,811 | +2.3% | 0.55% | -0.2% |
| Q1 2014 | $160,682,000 | -3.5% | 2,173,465 | +0.9% | 0.55% | -13.8% |
| Q4 2013 | $166,455,000 | +11.1% | 2,154,234 | -0.5% | 0.64% | -3.8% |
| Q3 2013 | $149,891,000 | +3.3% | 2,166,080 | -5.5% | 0.66% | +4.7% |
| Q2 2013 | $145,066,000 | – | 2,292,580 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |